During the past decade, New England Retina Associates conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "New England Retina Associates" #1 collaborator was "National Eye Institute (NEI)" with 3 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Regeneron Pharmaceuticals" with 2 trials as a collaborator, "Allergan" with 1 trials as a collaborator and "National Institutes of Health (NIH)" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "New England Retina Associates" are "Diabetic Macular Edema" (4 trials). Many other conditions were trialed in "New England Retina Associates" in a lesser frequency.

Most popular intervention types in "New England Retina Associates" are "Drug" (4 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "0.3 mg intravitreal ranibizumab" (1 trials), "1.25 mg intravitreal bevacizumab" (1 trials), "2.0 mg intravitreal aflibercept" (1 trials), "Deferred aflibercept" (1 trials) and "Deferred laser" (1 trials). Other intervention names were less common.

The vast majority of trials in "New England Retina Associates" are 4 trials for "All" genders.

Currently, there are NaN active trials in "New England Retina Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in New England Retina Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in New England Retina Associates, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".